{
  "trial_id": "NCT03158805",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Men and women, ages of 18-65 years, inclusive.",
      "label": "met"
    },
    {
      "criterion": "Participants will have a DSM-5 bipolar disorder that is clinically stable.",
      "label": "unknown"
    },
    {
      "criterion": "Participants will be obese (defined as a BMI \u2265 30 mg/kg2) or overweight (defined as BMI \u2265 27 kg/m2) with at least one weight-related comorbidity, such as hypertension, type 2 diabetes, or dyslipidemia.",
      "label": "met"
    },
    {
      "criterion": "Participants in treatment for a weight-related comorbidity (hypertension, type 2 diabetes, and/or dyslipidemia) must be on a stable and allowed treatment regimen for that condition for at least 3 months prior to study enrollment.",
      "label": "unknown"
    },
    {
      "criterion": "Participants will be able to provide informed consent before any trial-related activities.",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "dementia, a psychotic or depressive disorder, or a substance use disorder within the past three months;",
      "label": "triggers"
    },
    {
      "criterion": "those with clinically significant psychotic features or suicidal ideation;",
      "label": "triggers"
    },
    {
      "criterion": "those with serious or unstable general medical illnesses;",
      "label": "triggers"
    }
  ],
  "notes": "Patient has a history of dementia, psychosis, and substance use disorder within the past three months. They also have clinically significant psychotic features and suicidal ideation.",
  "_meta": {
    "topic_id": "14",
    "trial_id": "NCT03158805",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}